Trial Profile
Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis (EMPOWER)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jun 2017
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Acronyms EMPOWER
- Sponsors Allergan
- 12 Sep 2016 Status changed from active, no longer recruiting to completed.
- 28 Jan 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 22 Sep 2015 New trial record